Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioma × fludarabine × Clear all

Phase

Phase 1/2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 60 Multiple Myeloma 39 Lymphoma 35 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Leukemia, Lymphocytic, Chronic, B-Cell 33 Myelodysplastic Syndromes 31 Lymphoma, Non-Hodgkin 30 Leukemia 30 Recurrence 28 Lymphoma, B-Cell 28 Melanoma 25 Lymphoma, Large B-Cell, Diffuse 20 Lymphoma, Mantle-Cell 16 Ovarian Neoplasms 15 Neoplasms 15 Lymphoma, Follicular 15 Hematologic Neoplasms 15 Carcinoma, Non-Small-Cell Lung 14 Burkitt Lymphoma 13 Lymphoma, B-Cell, Marginal Zone 12 Hodgkin Disease 12 Carcinoma, Renal Cell 11 Neuroblastoma 10 Leukemia, Biphenotypic, Acute 10 Head and Neck Neoplasms 9 Graft vs Host Disease 9 Triple Negative Breast Neoplasms 8 Stomach Neoplasms 8 Neoplasms, Plasma Cell 8 Neoplasm Metastasis 8

Interventions

Temozolomide 39 Radiotherapy 13 Magnetic Resonance Spectroscopy 9 Bevacizumab 8 Surgical Procedures, Operative 7 Irinotecan 7 Radiation 6 Carboplatin 6 ribociclib 5 Specimen Handling 5 Radiosurgery 5 Nivolumab 5 Imiquimod 5 Flucytosine 5 Filgrastim 5 Erlotinib Hydrochloride 5 Carmustine 5 Aminolevulinic Acid 5 vandetanib 4 sargramostim 4 Topotecan 4 O(6)-benzylguanine 4 Imatinib Mesylate 4 IL13-PE38 4 Etoposide 4 Cyclophosphamide 4 Craniotomy 4 vocimagene amiretrorepvec 3 lentiviral minigene vaccine of COVID-19 coronavirus 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07480941 2026-03-18

DUAL-CAR-NK-GB

Beijing Biotech

Phase 1 Recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡